AbuO, a tolc-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1236-1245

  Srinivasan, Vijaya Bharathi ^a   Vaidyanathan, Vasanth ^a   Rajamohan, Govindan ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; BENZALKONIUM CHLORIDE; CARBENICILLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; KANAMYCIN; MEROPENEM; NALIDIXIC ACID; NEOMYCIN; OFLOXACIN; PROTEIN ABUO; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE; TICARCILLIN; TIGECYCLINE; TOLC PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARRIER PROTEIN; MINOCYCLINE; OUTER MEMBRANE PROTEIN;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; DOWN REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; METABOLISM;

ACINETOBACTER BAUMANNII; AMIKACIN; ANTI-INFECTIVE AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CARBENICILLIN; MEMBRANE TRANSPORT PROTEINS; MINOCYCLINE; OXIDATIVE STRESS; STREPTOMYCIN;

EID: 84921814950     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03626-14     Document Type: Article

References (48)

1. Tokuda H. 2009. Biogenesis of outer membranes in Gram-negative bacteria. Biosci Biotechnol Biochem 73:465-473. http://dx.doi.org/10.1271 /bbb.80778.
2. Perez A, Poza M, Aranda J, Latasa C, Medrano FJ, Tomas M, Romero A, Lasa I, Bou G. 2012. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob Agents Chemother 56:6256-6266. http: //dx.doi.org/10.1128/AAC.01085-12.
3. Bunikis I, Denker K, Ostberg Y, Andersen C, Benz R, Bergstrom S. 2008. An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds. PLoS Pathog 4:e1000009. http://dx.doi.org/10.1371/journal.ppat.1000009.
4. Horiyama T, Yamaguchi A, Nishino K. 2010. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 65:1372-1376. http://dx.doi.org/10.1093/jac /dkq160.
5. Lee S, Song S, Lee K. 2014. Functional analysis of TolC homologs in Vibrio vulnificus. Curr Microbiol 68:729-734. http://dx.doi.org/10.1007 /s00284-014-0537-4.
6. Ferhat M, Atlan D, Vianney A, Lazzaroni JC, Doublet P, Gilbert C. 2009. The TolC protein of Legionella pneumophila plays a major role in multi-drug resistance and the early steps of host invasion. PLoS One 4:e7732. http://dx.doi.org/10.1371/journal.pone.0007732.
7. Gil H, Platz GJ, Forestal CA, Monfett M, Bakshi CS, Sellati TJ, Furie MB, Benach JL, Thanassi DG. 2006. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A 103:12897-12902. http://dx.doi.org/10.1073/pnas .0602582103.
8. Wandersman C, Delepelaire P. 1990. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci U S A 87:4776-4780. http://dx.doi.org/10.1073/pnas.87.12.4776.
9. Hwang J, Zhong X, Tai PC. 1997. Interactions of dedicated export membrane proteins of the colicin V secretion system: CvaA, a member of the membrane fusion protein family, interacts with CvaB and TolC. J Bacteriol 179:6264-6270.
10. Delgado MA, Solbiati JO, Chiuchiolo MJ, Farías RN, Salomon RA. 1999. Escherichia coli outer membrane protein TolC is involved in production of the peptide antibiotic microcin J25. J Bacteriol 181:1968-1970.
11. Fralick JA. 1996. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 178:5803-5805.
12. Nishino K, Yamada J, Hirakawa H, Hirata T, Yamaguchi A. 2003. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to β-lactams. Antimicrob Agents Chemother 47:3030-3033. http://dx.doi .org/10.1128/AAC.47.9.3030-3033.2003.
13. Nishino K, Yamaguchi A. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 183:5803-5812. http: //dx.doi.org/10.1128/JB.183.20.5803-5812.2001.
14. Nishino K, Yamaguchi A. 2002. EvgA of the two-component signal transduction system modulates production of the yhiUV multidrug transporter in Escherichia coli. J Bacteriol 184:2319-2323. http://dx.doi.org/10.1128 /JB.184.8.2319-2323.2002.
15. Lomovskaya O, Lewis K. 1992. Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad SciUSA 89:8938-8942. http://dx.doi.org /10.1073/pnas.89.19.8938.
16. Kobayashi N, Nishino K, Hirata T, Yamaguchi A. 2003. Membrane topology of ABC-type macrolide antibiotic exporter MacB in Escherichia coli. FEBS Lett 546:241-246. http://dx.doi.org/10.1016/S0014 -5793(03)00579-9.
17. Kobayashi N, Nishino K, Yamaguchi A. 2001. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 183:5639-5644. http://dx.doi.org/10.1128/JB.183.19.5639-5644.2001.
18. Krishnamoorthy G, Tikhonova EB, Dhamdhere G, Zgurskaya HI. 2013. On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein. Mol Microbiol 87:982-997. http://dx.doi.org/10.1111/mmi.12143.
19. Lin CW, Huang YW, Hu RM, Yang TC. 2014. SmeOP-TolCSm efflux pump contributes to the multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 58:2405-2408. http://dx.doi.org/10 .1128/AAC.01974-13.
20. Perez A, Poza M, Fernández A, Fernández Mdel C, Mallo S, Merino M, Rumbo-Feal S, Cabral MP, Bou G. 2012. Involvement of the AcrABTolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 56:2084-2090. http://dx.doi.org /10.1128/AAC.05509-11.
21. Lister IM, Raftery C, Mecsas J, Levy SB. 2012. Yersinia pestis AcrABTolC in antibiotic resistance and virulence. Antimicrob Agents Chemother 56:1120-1123. http://dx.doi.org/10.1128/AAC.05338-11.
22. Fournier PE, Richet H. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42:692-699. http: //dx.doi.org/10.1086/500202.
23. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-538. http://dx .doi.org/10.1128/CMR.00058-07.
24. Durante-Mangoni E, Zarrilli R. 2011. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 6:407-422. http://dx.doi.org /10.2217/fmb.11.23.
25. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114-4123. http://dx.doi.org/10.1128/AAC.00778-06.
26. Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH. 2008. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol 46:2499-2507. http://dx.doi.org/10.1128/JCM .00367-08.
27. Bratu S, Landman D, Martin DA, Georgescu C, Quale J. 2008. Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob Agents Chemother 52:2999-3005. http://dx.doi.org/10.1128/AAC.01684-07.
28. Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, Marcon M, Gebreyes WA. 2009. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrob 8:21. http://dx.doi.org/10.1186/1476-0711-8-21.
29. Rajamohan G, Srinivasan VB, Gebreyes WA. 2010. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. J Antimicrob Chemother 65:228-232. http://dx.doi .org/10.1093/jac/dkp427.
30. Catel-Ferreira M, Coadou G, Molle V, Mugnier P, Nordmann P, Siroy A, Jouenne T, Dé E. 2011. Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. J Antimicrob Chemother 66:2053-2056. http://dx.doi.org /10.1093/jac/dkr267.
31. Smani Y, Dominguez-Herrera J, Pachon J. 2013. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. J Infect Dis 208:1561-1570. http://dx.doi.org/10.1093/infdis /jit386.
32. Smani Y, Pachon J. 2013. Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility. Antimicrob Agents Chemother 57:677. http://dx.doi.org/10.1128/AAC.01277-12.
33. Srinivasan VB, Venkataramaiah M, Mondal A, Vaidyanathan V, Govil T, Rajamohan G. 2012. Functional characterization of a novel outer membrane porin KpnO, regulated by PhoBR two-component system in Klebsiella pneumoniae NTUH-K2044. PLoS One 7:e41505. http://dx.doi .org/10.1371/journal.pone.0041505.
34. Srinivasan VB, Vasanth V, Mondal A, Rajamohan G. 2012. Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae. PLoS One 7:e33777. http://dx.doi.org/10.1371/journal.pone.0033777.
35. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
36. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. 2006. Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A 103:10414-10419. http://dx.doi.org/10.1073 /pnas.0604055103.
37. Lewis T, Loman NJ, Bingle L, Jumaa P, Weinstock GM, Mortiboy D, Pallen MJ. 2010. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 75:37-41. http://dx.doi.org/10.1016/j.jhin.2010 .01.012.
38. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2:e7. http://dx.doi.org/10 .1371/journal.pgen.0020007.
39. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21:601-614. http://dx.doi.org/10.1101 /gad.1510307.
40. Merrell DS, Bailey C, Kaper JB, Camilli A. 2001. The ToxR-mediated organic acid tolerance response of Vibrio cholerae requires OmpU. J Bacteriol 183: 2746 -2754. http://dx.doi.org/10.1128/JB.183.9.2746 -2754.2001.
41. Cosme AM, Becker A, Santos MR, Sharypova LA, Santos PM, Moreira LM. 2008. The outer membrane protein TolC from Sinorhizobium meliloti affects protein secretion, polysaccharide biosynthesis, antimicrobial resistance, and symbiosis. Mol Plant Microbe Interact 21:947-957. http://dx .doi.org/10.1094/MPMI-21-7-0947.
42. Nikaido E, Yamaguchi A, Nishino K. 2008. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium byRamAin response to environmental signals. J Biol Chem 283:24245-24253. http: //dx.doi.org/10.1074/jbc.M804544200.
43. Zgurskaya HI, Nikaido H. 1999. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci U S A 96:7190-7195. http://dx.doi.org/10.1073/pnas.96.13.7190.
44. Bina JE, Mekalanos JJ. 2001. Vibrio cholerae tolC is required for bile resistance and colonization. Infect Immun 69:4681-4685. http://dx.doi .org/10.1128/IAI.69.7.4681-4685.2001.
45. Baucheron S, Nishino K, Monchaux I, Canepa S, Maurel MC, Coste F, Roussel A, Cloeckaert A, Giraud E. 2014. Bile-mediated activation of the acrAB and tolC multidrug efflux genes occurs mainly through transcriptional derepression of ramA in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 69:2400-2406. http://dx.doi.org/10.1093/jac /dku140.
46. Hahn A, Stevanovic M, Mirus O, Schleiff E. 2012. The TolC-like protein HgdD of the cyanobacterium Anabaena sp. PCC 7120 is involved in secondary metabolite export and antibiotic resistance. J Biol Chem 287: 41126-41138. http://dx.doi.org/10.1074/jbc.M112.396010.
47. Tabata A, Nagamune H, Maeda T, Murakami K, Miyake Y, Kourai H. 2003. Correlation between resistance of Pseudomonas aeruginosa to quaternary ammonium compounds and expression of outer membrane protein OprR. Antimicrob Agents Chemother 47:2093-2099. http://dx.doi .org/10.1128/AAC.47.7.2093-2099.2003.
48. Tattawasart U, Maillard JY, Furr JR, Russell AD. 1999. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 42:219-229. http://dx.doi.org/10.1053/jhin.1999.0591.